| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5776433 | MYLAN SPECIALITY LP | Flunisolide aerosol formulations |
Jul, 2015
(8 years ago) | |
| US5980867 | MYLAN SPECIALITY LP | Flunisolide aerosol formulations |
Jul, 2018
(5 years ago) | |
Aerospan Hfa is owned by Mylan Speciality Lp.
Aerospan Hfa contains Flunisolide.
Aerospan Hfa has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Aerospan Hfa are:
- US5776433
- US5980867
Aerospan Hfa was authorised for market use on 27 January, 2006.
Aerospan Hfa is available in aerosol, metered;inhalation dosage forms.
The generics of Aerospan Hfa are possible to be released after 06 July, 2018.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-128) | Aug 28, 2016 |
Drugs and Companies using FLUNISOLIDE ingredient
Market Authorisation Date: 27 January, 2006
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
More Information on Dosage
AEROSPAN HFA family patents
